ARCELLX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.02 USD | -0.42% |
|
+0.23% | -6.27% |
| 31/05 | Piper Sandler Starts Arcellx With Overweight Rating, $70 Price Target | MT |
| 15/05 | Stifel Adjusts Price Target on Arcellx to $83 From $82, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARCELLX, INC. | Other Biotechnology & Medical Research | -0.42% | +0.23% | -6.27% | +23.89% | - | 2.78B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ACLX Stock
- Charts Arcellx, Inc.
- Comparison Chart
